These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6091579)

  • 21. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay.
    Mogil JS; Kest B; Sadowski B; Belknap JK
    J Pharmacol Exp Ther; 1996 Feb; 276(2):532-44. PubMed ID: 8632319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
    Nakazawa T; Furuya Y; Kaneko T; Yamatsu K; Yoshino H; Tachibana S
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1247-54. PubMed ID: 1969472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of tifluadom on cholecystokinin-induced antinociception.
    Gericke M; Morgenstern R; Ott T
    Eur J Pharmacol; 1990 May; 180(1):187-90. PubMed ID: 2365002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a kappa-agonist-like antinociceptive action of tifluadom.
    Upton N; Gonzalez JP; Sewell RD
    Neuropharmacology; 1983 Oct; 22(10):1241-2. PubMed ID: 6316195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D; Pick CG; Tive LA; Pasternak GW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacogenetic approach to the mechanisms of action of opiates.
    Oliverio A; Castellano C; Filibeck U
    Ann Ist Super Sanita; 1982; 18(1):13-6. PubMed ID: 6303180
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):330-6. PubMed ID: 1656027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist.
    Leander JD
    J Pharm Pharmacol; 1984 Aug; 36(8):555-6. PubMed ID: 6148404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
    Steinfels GF; Cook L
    J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of mu- and kappa-receptors by means of correlation of analgesic potency in vivo and receptor binding affinity in vitro of various opioid agonists.
    Ensinger HA; Stockhaus K; Merz H
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):649-53. PubMed ID: 6096651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice.
    Castellano C; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):561-3. PubMed ID: 6280203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF; Lahti RA; Ludens JH
    J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia.
    Smith FL; Brase DA; Dombrowski DS; Dewey WL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1177-85. PubMed ID: 7932169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: behavioral and biochemical correlations.
    Racagni G; Bruno F; Iuliano E; Paoletti R
    J Pharmacol Exp Ther; 1979 Apr; 209(1):111-6. PubMed ID: 219179
    [No Abstract]   [Full Text] [Related]  

  • 37. Unexpected opioid activity in a known class of drug.
    Römer D; Büscher HH; Hill RC; Maurer R; Petcher TJ; Zeugner H; Benson W; Finner E; Milkowski W; Thies PW
    Life Sci; 1982 Sep 20-27; 31(12-13):1217-20. PubMed ID: 6292610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The analgesic efficacy of partial opioid agonists is increased in mice with targeted inactivation of the alpha2A-adrenoceptor gene.
    Ozdoğan UK; Lähdesmäki J; Scheinin M
    Eur J Pharmacol; 2006 Jan; 529(1-3):105-13. PubMed ID: 16325800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.
    Raffa RB; Friderichs E; Reimann W; Shank RP; Codd EE; Vaught JL
    J Pharmacol Exp Ther; 1992 Jan; 260(1):275-85. PubMed ID: 1309873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.